Victor F. Tapson, M.D.

Dr. Tapson is Professor of Medicine, Duke University School of Medicine. Within the past 12 months, Dr. Tapson has received research grant support from Actelion, Cotherix, Encysive, Pfizer, Sanofi Aventis and United Therapeutics, and has been a consultant for Actelion, Sanofi Aventis and United Therapeutics.

This activity is made possible by an unrestricted educational grant from .

Release Date: 07/10/2007
Termination Date: 07/10/2010

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Upon completion of this Cyberounds^®, you should be able to:

• Describe underlying risk factors for venous thromboembolism
• Describe appropriate diagnostic approaches to suspected acute DVT and PE
• Discuss the mechanism of action of various anticoagulants
• Discuss the side-effect profiles of warfarin, UFH and LMWH
• Discuss results of clinical trials in VTE prevention and treatment.

 

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms of this CME activity